Skip to content

CRASH-3

CRASH-3 is a large, international, randomised, placebo controlled trial, to quantify the safety and effect on mortality and morbidity of the administration of tranexamic acid in patients with TBI.

https://crash3.lshtm.ac.uk/

START DATE

23 July 2012

END DATE

31 January 2019

EXISTING LOCATIONS